Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Sep 11:2014:bcr2014204013.
doi: 10.1136/bcr-2014-204013.

Risk of statin-induced rhabdomyolysis in patients with hepatic impairment

Nitin Kolhe  1 , Jeremy Lewis  1 , Thomas Alasdair McCulloch  2
Affiliations
Case Reports

Risk of statin-induced rhabdomyolysis in patients with hepatic impairment

Nitin Kolhe et al. BMJ Case Rep. .

Abstract

We describe a case of a 54-year-old man with a 2-month history of biliary colic associated with a common bile duct stone. He underwent laparoscopic cholecystectomy and developed postoperative acute kidney injury stage 3. A renal biopsy was performed and demonstrated myoglobin in the renal tubules. Retrospective creatine kinase analysis was suggestive of rhabdomyolysis. It is thought this was precipitated by simvastatin accumulation in the context of a period of hepatic impairment and elevated liver enzymes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Renal biopsy specimen with H&E staining, demonstrating acute tubular injury.
Figure 2
Figure 2
Renal biopsy specimen with immunoperoxidase staining for myoglobin in renal tubule.
See this image and copyright information in PMC

References

    1. Antons KA, Williams CD, Baker SK, et al. Clinical perspectives of statin-induced rhabdomyolysis. Am J Med 2006;119:400–9 - PubMed
    1. Brealey DA, Singer M, Terblanche M. Potential metabolic consequences of statins in sepsis. Crit Care Med 2011;39:1514–20 - PubMed
    1. Guyton JR. Benefit versus risk in statin treatment. Am J Cardiol 2006;97:95C–7C - PubMed
    1. Ito MK, Talbert RL, Tsimikas S. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction. Pharmacotherapy 2006;26:85S–97S - PubMed
    1. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495–504 - PubMed

Publication types